Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome - Contacts and Locations

Home

Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00003959. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003959

Locations


United States, New York
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Stephen D. Nimer, MD	Memorial Sloan-Kettering Cancer Center